Investigational Site Number 724002
Barcelona 08907
0 studies enrolling now · 14 studies all time
What they study most
Acute Coronary Syndrome, Arrhythmia Prophylaxis, Asthma, Diffuse Large B-cell Lymphoma, Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Multiple Sclerosis Relapse, Ovarian Cancer Recurrent, Prostate Cancer, Type 2 Diabetes Mellitus, Ventricular Arrhythmia
Studies at this site
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM) — Completed
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
- Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis — Completed
- Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma — Completed
- Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
- SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
- Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients — Completed
- Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death — Completed
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
- To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF) — Completed
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
- Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta — Stopped early